Bempedoic Acid Proves Clinical Benefits for the Statin-Intolerant
NEW ORLEANS — Bempedoic acid (Nexletol) provided compelling clinical benefit in terms of primary and secondary cardiovascular prevention for statin-intolerant patients who need cholesterol lowering, according to the CLEAR Outcomes trial. Cementing its place in the arsenal of nonstatin therapies, the ATP citrate lyase inhibitor met the primary endpoint in reducing major adverse cardiovascular events […]
Nonalcoholic fatty liver disease progression: New study shows role of adenosine kinase in fat deposition, liver inflammation
A study led by Texas A&M AgriLife Research provides compelling evidence of the important role of hepatocyte adenosine kinase in the progression of nonalcoholic fatty liver disease, NAFLD. The study, “Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation,” appeared in September in the scientific journal Gastroenterology. Hepatocytes are cells that play pivotal roles […]